Article
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer
4 May 2023
Abstract excerpt
BACKGROUND: Pancreatic cancer has a dismal prognosis. One reason is resistance to cytotoxic drugs. Molecularly matched therapies might overcome this resistance but the best approach to identify those patients who may benefit is unknown. Therefore, we sought to evaluate a molecularly guided treatment approach. MATERIALS AND METHODS: We retrospectively analyzed the clinical outcome and mutational status of patients...
Topics
Join the communities discussing this publication.
